Faisal Khashid
Analyst
Jefferies
Equibles does not estimate personal net worth.
About Faisal Khashid
Faisal Khashid is recorded as Analyst at Jefferies. Faisal Khashid has spoken on 3 earnings calls and 3 other investor events across 4 companies, most recently for Design Therapeutics, Inc. on June 4, 2026. Those appearances were for Design Therapeutics, Inc. (DSGN), Tvardi Therapeutics, Inc. (TVRD), Verastem, Inc. (VSTM) and Kymera Therapeutics, Inc. (KYMR). The companies whose calls Faisal Khashid spoke on are classified in the Healthcare sector.
Faisal Khashid on recent calls
“I'm one of the senior biotech analysts here at Jefferies. Really pleased to have with us here at Design Therapeutics. I have CEO Pratik Shah with me on the stage.”
“I'm one of the senior biotech analysts here at Jefferies. We're here live at the Jefferies Global Healthcare Conference in New York. Really pleased to have with us today management team of Tavarti Therapeutics, joined here on the stage by CEO Imran Alibai.”
“I'm one of the senior biotech analysts here at Jeffries. We're here live from the Jeffries Global Healthcare Conference in New York. Really pleased to have with us this morning the management team of Verisem Oncology, Jonathan Pachter, the chief scientific officer, as well as Dan Lyons, the chief commercial officer.”
“Wanted to ask, as you guys get the sites up and running in the Phase II B studies, do you expect to provide any kind of color or context around how enrollment is going in those studies?”
“I'm one of the senior biotech analysts here at Jefferies. Really pleased to have with us here at Design Therapeutics. I have CEO Pratik Shah with me on the stage.”
Affiliation history
-
Jefferies
Analyst
Transcript header (unverified)
Current
Company network
Verastem, Inc.
VSTM
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-06-03
View calls and events